(MedPage Today) — The investigational oral pre-exposure prophylaxis (PrEP) agent MK-8527 showed a similar, well-tolerated safety profile to placebo, with dose-proportional pharmacokinetics, among adults with a low likelihood of HIV-1 exposure…
Source link : https://www.medpagetoday.com/meetingcoverage/ias/116568
Author :
Publish date : 2025-07-18 14:50:00
Copyright for syndicated content belongs to the linked Source.
